gemfibrozil has been researched along with retinol in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Breslow, JL; Eisenberg, S; Weintraub, MS | 1 |
Hilden, H; Syvänne, M; Taskinen, MR; Vuorinen-Markkola, H | 1 |
Cousins, M; Edwards, AL; Nakajima, K; Ooi, DS; Ooi, TC | 1 |
1 review(s) available for gemfibrozil and retinol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for gemfibrozil and retinol
Article | Year |
---|---|
Gemfibrozil reduces postprandial lipemia in non-insulin-dependent diabetes mellitus.
Topics: Arteriosclerosis; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diterpenes; Female; Food; Gemfibrozil; Humans; Lipids; Lipoproteins; Male; Middle Aged; Retinyl Esters; Triglycerides; Vitamin A | 1993 |
5 other study(ies) available for gemfibrozil and retinol
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.
Topics: Cholestyramine Resin; Chylomicrons; Dietary Fats; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Lipoproteins; Male; Pentanoic Acids; Triglycerides; Valerates; Vitamin A | 1987 |
Effect of fibrates on postprandial remnant-like particles in patients with combined hyperlipidemia.
Topics: Cholesterol; Dietary Fats; Diterpenes; Fasting; Female; Fenofibrate; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Postprandial Period; Retinyl Esters; Triglycerides; Vitamin A | 2004 |